Rhumbline Advisers Calliditas Therapeutics Ab Transaction History
Rhumbline Advisers
- $105 Billion
- Q2 2024
A detailed history of Rhumbline Advisers transactions in Calliditas Therapeutics Ab stock. As of the latest transaction made, Rhumbline Advisers holds 202 shares of CALT stock, worth $8,080. This represents 0.0% of its overall portfolio holdings.
Number of Shares
202
Previous 164
23.17%
Holding current value
$8,080
Previous $3,000
133.33%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding CALT
# of Institutions
22Shares Held
842KCall Options Held
8.5KPut Options Held
26.6K-
Bvf Inc San Francisco, CA750KShares$30 Million0.89% of portfolio
-
Ironwood Investment Management LLC Boston, MA25.6KShares$1.03 Million0.56% of portfolio
-
Optiver Holding B.V. Amsterdam, P722.3KShares$893,4400.02% of portfolio
-
Crossmark Global Holdings, Inc.16.1KShares$644,6800.01% of portfolio
-
Ubs Group Ag10.8KShares$430,2400.0% of portfolio
About Calliditas Therapeutics AB
- Ticker CALT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,624,800
- Market Cap $1.06B
- Description
- Calliditas Therapeutics AB (publ), a clinical-stage biopharmaceutical company, focused on identifying, developing, and commercializing pharmaceuticals products for treatments in orphan indications with initial focus on renal and hepatic diseases. It offers Nefecon, an oral formulation of budesonide that is an immunosuppressant for the treatment ...